Company: PACB
Filing Date: 2025-11-06
Form Type: 10-Q
Source: 0001299130-25-000168
Chunk: 43

Company: PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Filing Date: 2025-11-06
Form: 10-Q
Item: Part I, Item 1
Chunk 43
---
 September 30,(In thousands, except percentages)20252024$ Change% ChangeRevenue:Product revenue $32,597 $35,296 $(2,699)(8%)Service and other revenue 5,844 4,671 1,173 25%Total revenue 38,441 39,967 (1,526)(4%)Cost of Revenue:Cost of product revenue 19,204 23,278 (4,074)(18%)Cost of service and other revenue 3,078 3,484 (406)(12%)Amortization of acquired intangible assets183 3,201 (3,018)(94%)Loss on purchase commitment75 — 75 — Total cost of revenue 22,540 29,963 (7,423)(25%)Gross profit15,901 10,004 5,897 59%Operating Expense:Research and development 22,846 25,516 (2,670)(10)%Sales, general and administrative 31,099 43,746 (12,647)(29)%Amortization of acquired intangible assets833 3,649 (2,816)(77)%Change in fair value of contingent consideration— 1,170 (1,170)(100)%Total operating expense 54,778 74,081 (19,303)(26%)Operating loss (38,877)(64,077)25,200 (39)%Interest expense (1,739)(3,538)1,799 (51)%Other income, net 2,999 6,890 (3,891)(56%)Loss before income taxes(37,617)(60,725)23,108 (38%)Income tax provision383 — 383 — Net loss$(38,000)$(60,725)$22,725 (37%)

Q3 Fiscal 2025 Form 10-Q30

Revenue

Total Revenue

Total revenue decreased $1.6 million, or 4%, for the third quarter of 2025 compared with the same quarter of 2024.Product revenue decreased $2.7 million, or 8%, primarily due to a decrease of $5.5 million, or 33%, in instrument revenue, partially offset by an increase of $2.8 million, or 15%, in consumable revenue.Service and other revenue increased $1.1 million, or 25